[Epidemiology of chronic kidney disease stage V treated in southeastern Algeria: prospective study from 2016 to 2018].

Introduction: Chronic kidney disease stage V, by its incidence and its prevalence which are constantly increasing in the world and in Algeria, the morbidity and mortality it generates, the high cost of its treatment, represents a major public health issue. Our objective is to describe the epidemiology of stage V chronic kidney disease treated in south-eastern Algeria.

Patients And Methods: In our regional, multicenter, prospective descriptive study, all patients with stage V chronic kidney disease, residing and treated in south-eastern Algeria between September 1, 2016, and December 31, 2017, were included and followed up until December 31, 2018.

Impact of the Living Donor Age and the Hormonal Profile of Algerian Renal Transplant Recipients.

Kidney transplantation is the best treatment received by an uremic patient. One of the major advantages of transplantation is restoring a hormonal profile as before the chronic kidney disease. However, the posttransplant state depends on several factors including the quality of the graft.